STING pathway expression in low‐grade serous carcinoma of the ovary: an unexpected therapeutic opportunity?

• Main Authors: Jutta Huvila (Author), Dawn R Cochrane (Author), Monica Ta (Author), Christine Chow (Author), Kendall Greening (Author), Samuel Leung (Author), Anthony N Karnezis (Author), Analisa DiFeo (Author), David G Huntsman (Author)
• Format: Book
• Published: Wiley, 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Ovarian carcinoma histotypes are distinct diseases with variable clinical outcomes and response to treatment. There is a need for new subtype‐specific treatment modalities, especially for women with widespread and chemo‐resistant disease. Stimulator of interferon genes (STING) is a part of...